Company Description
Minerva Surgical, Inc., a commercial-stage medical technology company, develops, manufactures, and commercializes minimally invasive solutions to meet the uterine healthcare needs of women in the United States.
The company provides Minerva ES Endometrial Ablation System and Genesys HTA Endometrial Ablation System, which are endometrial ablation devices; Symphion Tissue Removal System, a minimally invasive uterine tissue removal system to combine bladeless tissue resection and coagulation, continuous visualization, and intrauterine pressure monitoring; and Resectr Tissue Resection Device, a handheld surgical instrument to enable the hysteroscopic removal and diagnosis of endometrial polyps.
Its devices are utilized by obstetrician-gynecologists in various medical treatment settings, including hospitals, ambulatory surgical centers, and physician offices.
The company was incorporated in 2008 and is headquartered in Santa Clara, California.
| Country | Canada |
| Founded | 2008 |
| IPO Date | Oct 22, 2021 |
| Industry | Medical Devices |
| Sector | Healthcare |
| Employees | 174 |
| CEO | Todd Usen |
Contact Details
Address: 4255 Burton Drive Santa Clara, California 95054 United States | |
| Phone | (855) 646-7874 |
| Website | minervasurgical.com |
Stock Details
| Ticker Symbol | UTRS |
| Exchange | OTCMKTS |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $12.00 |
| CIK Code | 0001452965 |
| CUSIP Number | 60343F106 |
| ISIN Number | SE0000697948 |
| Employer ID | 26-3422906 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| Todd Usen | President, Chief Executive Officer and Director |
| Greg Simbro | Vice President of Finance |
| Erik Reese | Vice President of Sales |
| Wendy Bowman | Vice President of Human Resources |
| Dr. Evgueni V. Skalnyi M.D. | Chief Medical Officer |
| Joanne Long | Vice President of Corporate Controller |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 4, 2024 | 15-12G | Securities registration termination |
| Dec 26, 2023 | 25 | Filing |
| Dec 26, 2023 | S-8 POS | Securities to be offered to employees in employee benefit plans, post-effective amendments |
| Dec 15, 2023 | 8-K | Current Report |
| Nov 13, 2023 | 10-Q | Quarterly Report |
| Nov 13, 2023 | 8-K | Current Report |
| Nov 2, 2023 | SC 13E3/A | [Amend] Going private transaction by certain issuers |
| Nov 2, 2023 | 8-K | Current Report |
| Oct 13, 2023 | 8-K | Current Report |
| Sep 29, 2023 | 8-K | Current Report |